Stanley Druckenmiller's position in Verona Pharma Plc is currently worth $58.8 Million. That's 1.69% of their equity portfolio (15th largest holding). The stake costed the investor $24.5 Million, netting the investor a gain of 140% so far.
Avg closing price
Price range
Increased shares by 29.4% (+202 Thousand shares)
Q4 2024